The IBD SmartSelect Composite Rating for Stevanato Group rose from 94 to 96 Wednesday.
Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets
The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The top-performing stocks tend to have a 95 or better grade as they start a significant move so be sure to keep that in mind when looking for the best stocks to buy and watch.
Stevanato Group is currently forming a cup without handle, with a 28.00 buy point. See if the stock can break out in volume at least 40% higher than normal.
The stock has a 94 EPS Rating, which means its recent quarterly and annual earnings growth tops 94% of all stocks.
Its Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
The company reported a 30% rise in earnings for Q2. Top line growth increased 19%, up from 9% in the prior quarter. The company has now posted increasing growth in each of the last two quarters.
Stevanato Group earns the No. 4 rank among its peers in the Medical-Services industry group. GeneDx Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
